ACTRN12612000622808进行中(未招募)3 期
A Randomised, Double-blind, Placebo-controlled, Clinical Trial to Compare the Safety and Efficacy of Reduced Dose Efavirenz (EFV) With Standard Dose EFV Plus Two Nucleotide Reverse Transcriptase Inhibitors (N(t)RTI) in Antiretroviral-naive HIV-infected Individuals Over 96 Weeks
Kirby Institute, Univeristy of New South Wales0 个研究点目标入组 124 人开始时间: 2012年6月8日最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 进行中(未招募)
- 发起方
- 入组人数
- 124
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 16 Years 至 o limit(—)
- 性别
- All
入选标准
- •All subjects entering into the main study protocol at participating centres will be eligible to enter this sub-study
排除标准
- •Existing neurological brain disease
- •Recent (<6months ) head injury
- •Current major depression or psychosis
- •Current alcohol abuse
- •Intended use of recreational drugs during study period
- •Uncontrolled medical conditions deemed to potentially interfere with cognitive function (e.g. uncontrolled diabetes, pyrexial illness, uraemia etc)
研究者
相似试验
进行中(未招募)
不适用
A Randomized, Double-blind, Placebo-controlled, Clinical Outcome study of ARC1779 Injection in Patients with Thrombotic Microangiopathy - Study of ARC1779 Injection in Patients with Thrombotic MicroangiopathyEUCTR2008-001872-54-ATArchemix Corp.100
进行中(未招募)
不适用
A Randomized, Double-blind, Placebo-controlled, Clinical Outcome Study of ARC1779 Injection in Patients with Thrombotic Microangiopathy. - Study of ARC1779 Injection in Patients with Thrombotic MicroangiopathyThrombotic microangiopathy (TMA) disordersMedDRA version: 9.1Level: LLTClassification code 10009731Term: Coagulation disorderEUCTR2008-001872-54-GBArchemix Corp100
已完成
3 期
A study to test the safety of a new trivalent seasonal influenza vaccine in healthy volunteersCTRI/2014/10/005107Cadila Pharmaceuticals Limited450
已完成
3 期
A study to test the safety of a new H1N1 influenza vaccine in healthy volunteersCTRI/2014/06/004707Cadila Pharmaceuticals Limited450
进行中(未招募)
不适用
A Randomized, Double-blind, Placebocontrolled, Clinical Outcome Study of ARC1779 Injection in Patients with Thrombotic Microangiopathy - NDThromobotic microangiopathy (TMA) disordersMedDRA version: 9.1Level: LLTClassification code 10009731Term: Coagulation disorderEUCTR2008-001872-54-ITARCHEMIX CORP100
